Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-25 @ 2:06 AM
NCT ID:
NCT03827460
Eligibility Criteria:
Inclusion Criteria:
* Moderate social drinkers
* Able to understand/complete questionnaires and procedures in English
* Body mass index (BMI) between 18.5 and 32 kg/m2
* Have venous access sufficient to allow blood sampling
Exclusion Criteria:
* Pregnant or breast-feeding women, or women who intend to become pregnant
* Do not attest to using accepted forms of birth control for the infusion phase of the study
* Current treatment for, or desire to be treated for, any substance use disorder or court ordered to not drink alcohol
* History of significant adverse reaction to alcohol
* Medical disorders or other conditions such as alcohol withdrawal seizures or delirium tremens that may influence study outcome or participant safety
* Medications (past 30 days) that could influence data or participant safety (e.g. antidepressants, antipsychotics, benzodiazepines, etc.) as determined by investigators
* DSM 5 Disorders (non AUD) or current/history of neurological disease of cerebral origin, or head injury with \> 20 min loss of consciousness
* Positive breath alcohol reading on arrival at any study visit
* Actively suicidal (for example, any suicide attempts within the past year or any current suicidal intent, including a plan) or are at serious suicidal risk, by clinical judgment of the investigator
* Any condition for which the principal investigators determine it is unsafe or not prudent to enroll
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
35 Years
Study:
NCT03827460
Study Brief:
Protocol Section:
NCT03827460